Skip to main content
. 2015 Jul 21;29(4):213–219. doi: 10.3341/kjo.2015.29.4.213

Fig. 2. Comparison of M22 thyrotropin-binding inhibitory immunoglobulin (TBII) value with (A) clinical activity score (CAS) score and (B) NOSPECS score. Unlike Mc4 thyroid-stimulating immunoglobulin, M22-TBII was not correlated with any of disease activity (p = 0.053) or severity score (p = 0.097).

Fig. 2